Endoscopic Histoacryl Obliteration vs. Propranolol in the Prevention of Esophagogastric Variceal Rebleeding: A Randomized Trial

Background and Study Aims: The obliteration of esophageal and/or gastric varices using Histoacryl is highly effective in controlling active bleeding. However, it is not known whether repeated injections are useful for the long-term eradication of esophagogastric varices. The aim of the study was to compare endoscopic Histoacryl obliteration with propranolol in the secondary prevention of esophagogastric variceal bleeding.
Patients and Methods: Between August 1995 and February 1999, 41 patients with a first bleeding from esophageal (n = 31) or gastric (n = 10) varices were included in the study. After primary hemostasis with obliteration using Histoacryl, patients were randomly allocated either to undergo complete Histoacryl obliteration of the remaining varices (group A, n = 21) or to long-term propranolol administration (group B, n = 20), for the prevention of rebleeding.
Results: The two groups were well matched for age, sex, etiology of cirrhosis, Child-Pugh score, renal function, and infection at the time of admission. The median follow-up was 31.9 months (4.8 - 74.7) for group A and 23.2 months (3.0 - 70.0) for group B. Initial hemostasis was achieved in 40/41 patients (97 %). No significant difference was observed between groups A and B with regard to the incidence of early rebleeding (during the first 6 weeks; 5/21 and 3/20), bleeding-related deaths by 6 weeks (3/21 and 6/20), long-term rebleeding (11/21 and 5/20), or overal number of deaths (9/21 and 9/20). The incidence of complications was higher in group A (10/21) than group B (2/20) (P < 0.03).
Conclusions: Repeated injections of Histoacryl with the aim of eradicating esophagogastric varices are associated with more complications compared with beta-blocker administration, with similar results in terms of rebleeding rate and survival in the long term.

References

• 1 D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach.  Semin Liver Dis. 1999;  19 475-505
• 2 de Franchis R, Primignani M. Endoscopic treatments for portal hypertension.  Semin Liver Dis. 1999;  19 439-455
• 3 Sarin S K, Lahoti D, Saxena S P. et al . Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients.  Hepatology. 1992;  16 1343-1349
• 4 Ramond M J, Valla D, Gotlib J P, Rueff B, Benhamou J P. [Endoscopic obturation of esophagogastric varices with bucrylate. I. Clinical study of 49 patients].  Gastroenterol Clin Biol. 1986;  10 575-579
• 5 Soehendra N, Nam V C, Grimm H, Kempeneers I. Endoscopic obliteration of large esophagogastric varices with bucrylate.  Endoscopy. 1986;  18 25-26
• 6 Thakeb F, Salama Z, Salama H, Abdel R T. et al . The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices.  Endoscopy. 1995;  27 358-364
• 7 Maluf-Filho F, Sakai P, Ishioka S, Matuguma S E. Endoscopic sclerosis versus cyanoacrylate endoscopic injection for the first episode of variceal bleeding: a prospective, controlled, and randomized study in Child-Pugh class C patients.  Endoscopy. 2001;  33 421-427
• 8 Feretis C, Dimopoulos C, Benakis P. et al . N-butyl-2-cyanoacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study.  Endoscopy. 1995;  27 355-357
• 9 Lo G H, Lai K H, Cheng J S. et al . A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices.  Hepatology. 2001;  33 1060-1064
• 10 Sarin S K, Jain A K, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices.  Am J Gastroenterol. 2002;  97 1010-1015
• 11 Ramond M J, Valla D, Mosnier J F. et al . Successful endoscopic obturation of gastric varices with butyl cyanoacrylate.  Hepatology. 1989;  10 488-493
• 12 de Franchis R. Portal Hypertension II. Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic strategies. Oxford; Blackwell Science 1996
• 13 Westaby D, Macdougall B R, Melia W. et al . A prospective randomized study of two sclerotherapy techniques for esophageal varices.  Hepatology. 1983;  3 681-684
• 14 Sarin S K, Lahoti D. Management of gastric varices.  Baillières Clin Gastroenterol. 1992;  6 527-548
• 15 Ready J, Rector W G Jr. Systemic hemodynamic changes in portal hypertension.  Semin Gastrointest Dis. 1995;  6 134-139
• 16 Bernard B, Grange J D, Khac E N. et al . Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.  Hepatology. 1999;  29 1655-1661
• 17 de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.  J Hepatol. 2000;  33 846-852
• 18 Watanabe K, Kimura K, Matsutani S. et al . Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization.  Gastroenterology. 1988;  95 434-440
• 19 Burroughs A K, Mezzanotte G, Phillips A. et al . Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates.  Hepatology. 1989;  9 801-807
• 20 Bohnacker S, Maydeo A, Soehendra N. Variceal bleeding and portal hypertension: still a therapeutic challenge?.  Endoscopy. 1999;  31 26-37
• 21 Bernard B, Cadranel J F, Valla D. et al . Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study.  Gastroenterology. 1995;  108 1828-1834
• 22 Goulis J, Armonis A, Patch D. et al . Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage.  Hepatology. 1998;  27 1207-1212
• 23 Goulis J, Patch D, Burroughs A K. Bacterial infection in the pathogenesis of variceal bleeding.  Lancet. 1999;  353 139-142
• 24 Graham D Y, Smith J L. The course of patients after variceal hemorrhage.  Gastroenterology. 1981;  80 800-809
• 25 Sarin S K, Govil A, Jain A K. et al . Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence.  J Hepatol. 1997;  26 826-832
• 26 Tanoue K, Hashizume M, Wada H. et al . Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: a prospective study.  Gastrointest Endosc. 1992;  38 582-585
• 27 Soehendra N, Grimm H, Nam V C, Berger B. N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy.  Endoscopy. 1987;  19 221-224
• 28 D’Imperio N, Piemontese A, Baroncini D. et al . Evaluation of undiluted N-butyl-2-cyanoacrylate in the endoscopic treatment of upper gastrointestinal tract varices.  Endoscopy. 1996;  28 239-243